To test ARPS for this capability, we extracted genomic DNA from known EGFR-mutated tumor cell lines mixed with increasing amounts of wild-type DNA (the total amount of DNA was 300 ng) to assess the sensitivity of our method. This evidence concerns the gene EGFR and neoplasm.